| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT07584083 Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) |
Recruitment opened |
| 2026-06-03 | NCT07430306 A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in… |
Trial sites expanded: 73 -> 79 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06594068 | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in… | Systemic Lupus Erythematosus | Recruiting |
| Phase 3 | |||
| NCT05835310 | An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus… | Systemic Lupus Erythematosus | Recruiting |
| NCT07430306 | A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in… | Systemic Lupus Erythematosus | Recruiting |
| NCT05138133 | Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis | Lupus Nephritis | Active, Not Recruiting |
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Active, Not Recruiting |
| Phase 2 | |||
| NCT05440422 | The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic… | Systemic Lupus Erythematosus | Recruiting |
| NCT07584083 | Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) | Antiphospholipid Syndrome (APS) | Recruiting |
| NCT06374212 | Anifrolumab for Hidradenitis Suppurativa | Hidradenitis Suppurativa | Active, Not Recruiting |
| Not specified | |||
| NCT06673043 | Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus | Lupus Erythematosus, Systemic | Recruiting |
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | Systemic Lupus Erythematosus | Recruiting |
| NCT06795893 | The Anifrolumab PRIM Program | Systemic Lupus Erythematosus | Recruiting |
| NCT07330245 | Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With… | Lupus Erythematosus, Systemic | Recruiting |
| NCT06659029 | Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users | Systemic Lupus Erythematosus | Recruiting |
| NCT07431775 | Saphnelo Use in Females of Child-bearing Potential | Systemic Lupus Erythematosus | Not Yet Recruiting |